Found 12 matching trials
Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery NA RATIONALE: Drugs used in chemotherapy, such as doxorubicin, work in differe...
Show More Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Learn More & Join Trial
LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From Melanoma NA The purpose of this study is to determine if LC beads loaded with Doxorubic...
Show More Location
University of Louisville
Learn More & Join Trial
Study in the Treatment of HCC With a Radiopaque (RO) Bead (LC Bead LUMI™) Loaded With Doxorubicin NA Hepatocellular carcinoma (HCC) is the most common type of primary liver can...
Show More Location
Multiple Locations
Learn More & Join Trial
Doxorubicin-eluting LC Bead M1 for Patients With Hepatocellular Carcinoma PHASE2 The purpose of this study is to determine the feasibility and safety of usi...
Show More Location
The Johns Hopkins Hospital
Learn More & Join Trial
Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab PHASE1 This is a multicentre, open labeled, controlled phase study designed to ass...
Show More Location
Clearview Cancer Center
Learn More & Join Trial
Drug-Eluting Bead, Irinotecan Therapy for Unresectable Intrahepatic Cholangiocarcinoma w/Concomitant Gemcitabine and Cisplatin or Carboplatin PHASE2 The purpose of this study is to find out if the combination of trans-arteri...
Show More Location
University of Louisville
Learn More & Join Trial
Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma PHASE2 This study will combine two therapies to treat patients with unresectable h...
Show More Location
The Johns Hopkins Hospital
Learn More & Join Trial
Survival Analysis: TACE vs. Combination Therapy in HCC N/A This retrospective observational study aimed to assess potential improvemen...
Show More Location
First Affiliated Hospital, Medical College of Zhejiang University
Learn More & Join Trial
Irinotecan -Eluting LC Bead-M1 (DEBIRI-M1) for Patients With Liver Metastases From Colorectal Cancer PHASE2 Purpose:
The purpose of this study is to determine the feasibility and saf...
Show More Location
The Johns Hopkins Hospital
Learn More & Join Trial
The LC Bead Trial; Transarterial Chemoembolization of Hepatocellular Carcinoma (HCC)With a Drug-eluting Bead NA This study involves the combined use of the FDA approved device, LC Bead an...
Show More Location
Barnes-Jewish Hospital/Washington Univesity School of Medicine
Learn More & Join Trial